ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
N Varveris Moda Bagno Sa

N Varveris Moda Bagno Sa (0MQS)

0.49
0.00
(0.00%)
Closed February 10 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.49
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.49 52 Week Range 0.49
Market Cap
Previous Close
0.49
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
18,810,000
Dividend Yield
-
PE Ratio
2.26
Earnings Per Share (EPS)
0.22
Revenue
22.79M
Net Profit
4.07M

About N Varveris Moda Bagno Sa

Sector
Industrial Supplies-whsl
Industry
Industrial Supplies-whsl
Headquarters
Athens, Attica, Grc
Founded
-
N Varveris Moda Bagno Sa is listed in the Industrial Supplies-whsl sector of the London Stock Exchange with ticker 0MQS. The last closing price for N Varveris Moda Bagno was 0.49 €. Over the last year, N Varveris Moda Bagno shares have traded in a share price range of 0.49 € to 0.49 €.

N Varveris Moda Bagno currently has 18,810,000 shares outstanding. The market capitalization of N Varveris Moda Bagno is 9.22 € million. N Varveris Moda Bagno has a price to earnings ratio (PE ratio) of 2.26.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.490.490.4900DE
4000.490.490.4900DE
12000.490.490.4900DE
26000.490.490.4900DE
52000.490.490.4900DE
156000.490.490.4900DE
260000.490.490.4900DE

0MQS - Frequently Asked Questions (FAQ)

What is the current N Varveris Moda Bagno share price?
The current share price of N Varveris Moda Bagno is 0.49 €
How many N Varveris Moda Bagno shares are in issue?
N Varveris Moda Bagno has 18,810,000 shares in issue
What is the market cap of N Varveris Moda Bagno?
The market capitalisation of N Varveris Moda Bagno is EUR 9.22M
What is the 1 year trading range for N Varveris Moda Bagno share price?
N Varveris Moda Bagno has traded in the range of 0.49 € to 0.49 € during the past year
What is the PE ratio of N Varveris Moda Bagno?
The price to earnings ratio of N Varveris Moda Bagno is 2.26
What is the cash to sales ratio of N Varveris Moda Bagno?
The cash to sales ratio of N Varveris Moda Bagno is 0.4
What is the reporting currency for N Varveris Moda Bagno?
N Varveris Moda Bagno reports financial results in EUR
What is the latest annual turnover for N Varveris Moda Bagno?
The latest annual turnover of N Varveris Moda Bagno is EUR 22.79M
What is the latest annual profit for N Varveris Moda Bagno?
The latest annual profit of N Varveris Moda Bagno is EUR 4.07M
What is the registered address of N Varveris Moda Bagno?
The registered address for N Varveris Moda Bagno is 50 ANAPAFSEOS STR, CHALANDRI, ATHENS, ATTICA, 15235
What is the N Varveris Moda Bagno website address?
The website address for N Varveris Moda Bagno is www.modabagno.gr
Which industry sector does N Varveris Moda Bagno operate in?
N Varveris Moda Bagno operates in the INDUSTRIAL SUPPLIES-WHSL sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RAIRa International Group Plc
1.00p
(25.00%)
2.27M
EUAEurasia Mining Plc
6.225p
(24.50%)
128.03M
THRUThruvision Group Plc
4.00p
(23.08%)
416.17k
AYMAnglesey Mining Plc
0.80p
(18.52%)
2.2M
BELLBelluscura Plc
2.25p
(18.42%)
9.83M
GUSGusbourne Plc
21.00p
(-44.74%)
584.95k
SYMESupply@me Capital Plc
0.0015p
(-33.33%)
1.12B
SCGLSealand Capital Galaxy Limited
2.75p
(-23.18%)
22.85M
EPPEnergypathways Plc
5.75p
(-20.14%)
3.87M
DEMGDeltex Medical Group Plc
0.0325p
(-18.75%)
50.08M
NTVONativo Resources Plc
0.0015p
(-11.76%)
7.03B
PREMPremier African Minerals Limited
0.0215p
(-2.27%)
1.18B
SYMESupply@me Capital Plc
0.0015p
(-33.33%)
1.12B
ORCPOracle Power Plc
0.019p
(9.20%)
733.62M
MSMNMosman Oil And Gas Limited
0.0385p
(-3.75%)
362.49M

Discussion

View Full Feed
LakeshoreLeo1953 LakeshoreLeo1953 1 minute ago
That you are asking the question probably gives you the answer.
20% is useful for continued dialogue
60% is likely juvenile posturing with
little tethering to reality.
10% is paid hype
10% is paid trash talk
I wouldn’t even rollover for those jobs
and
AVXL
Bubae Bubae 1 minute ago
A little help with your rocketry analogies maybe? How about "rapid unscheduled disassembly" 🙃 The stock was dropped 38% between your December 10th comment to December 17th. We are down 59% from the liftoff statement of December 26th. You have been here since the October promotion that fleece
RDAR
janice shell janice shell 2 minutes ago
Now you can be an Iggles Expert. Become a auperfan!
dukeb dukeb 3 minutes ago
I think it's pretty obvious what HMBL has in store for those vacant lots. Take a look at the image below. It's a PERFECT FIT!

https://investorshub.advfn.com/uimage/uploads/2025/2/10/onclgDisneyland.png
HMBL
9Coastal 9Coastal 3 minutes ago
True. June will sneak up before long. For the moment, I'm going with no news is good news. I'm sure they are aligning and want an IPO as much as we.
WHEN
sirant sirant 3 minutes ago
Yep that's what I am thinking also. 

GO $MCIC 
MCIC
stealofadeal stealofadeal 3 minutes ago
$KRTL No selling so next leg up coming.
KRTL
misterfishman misterfishman 5 minutes ago
True and no less than .25 cents in future.
IGPK
TucsonPhil TucsonPhil 6 minutes ago
Crickets
KGKG
gorbec1 gorbec1 6 minutes ago
Yep sounds right
MCIC
BullNBear52 BullNBear52 6 minutes ago
Chocolate-Amaretto Pudding Cake

I've had that before without the Amaretto.
Serve this warm with a scoop (or two) of creamy vanilla ice cream to help balance the rich flavor of the chocolate...

Oh my wife would eat it if it has chocolate in it. Then get up early
janice shell janice shell 7 minutes ago
That makes sense. People watch and play basketball all over the world. But if the Saudis want to do that, they'll have competition.
misterfishman misterfishman 7 minutes ago
Its a scam nothing more.
KEGS
Brapp Brapp 7 minutes ago
Beautifully real and deliciously petty.

On my front, I shifted production to NGLs today. I should apply for one of those plant derived carbon neutral credits.
TGLO
newmedman newmedman 8 minutes ago
Expect more of that in the future. That's why we need to be really diligent now. Especially with all these mentally challenged individuals that bet their lives on the next tweet.

The truth must be told.

[yt]2FBACT2XbXw[/yt]
DoF DoF 8 minutes ago
Social Safe is already trademarked to World Data Exchange Holdings Pty Ltd, 160 Hawkesbury Road, Westmead, NSW, via the USPTO/
HPNN
katiesdad7 katiesdad7 8 minutes ago
AI agrees with me that the 15th is about right for an update. However the company may just stay silent and not release anything.  This may be a smart move. As the old saying goes no news is good news. 

We all feel the pain and want something to happen. 
CBRF
Skankhunt43 Skankhunt43 9 minutes ago
"We're all dennis down here"
DPLS
SkyLimit2022 SkyLimit2022 9 minutes ago
xkr,

Thanks for asking again 😶

I encourage you to seek your own reliable sources and conduct thorough research for yourself…

In my view as an individual investor, there is no known limit to the potential combinations for DCVax-L, Direct, or the Ro
NWBO
WALLnut WALLnut 9 minutes ago
Your 'one and done' fantasy is nothing but marketing smoke—and your Betaglue YntraDose is just a tired, overhyped gimmick. In real oncology, treatments evolve with adaptive, multi-dose regimens. Radiogel’s smart, precise approach leaves one-shot promises like Betaglue YntraDose in the dust.
RDGL
jackson73 jackson73 10 minutes ago
MGOL, BHAT, OCEA ww ah action for tomorrow 
BHAT MGOL OCEA
fuagf fuagf 10 minutes ago
On protection if vaccinated 30-40 years ago can't see anything either, yet. This 25 years old no help on that

Protection after Two Doses of Measles Vaccine Is Independent of Interval between Doses Get access Arrow
, , , , ,
The Journal of Infectious Diseases, Volume 1
blackcat blackcat 10 minutes ago
And that could give a whole new meaning to "The Empire Strikes back"!!
Student of the Game Student of the Game 10 minutes ago
There are MANY drugs in various stages of clinical and preclinical trials for Alzheimers disease, and there won't be just one winner. The Acumen drug Sabirnitug looks to have a better safety profile against ARIA and has a totally different target mechanism than approved drugs. The current Phase II
ABOS